Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Little Green Pharma's Enterprise Value is A$55.75 Mil.
Little Green Pharma's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was A$-1.09 Mil. Therefore, Little Green Pharma's EV-to-EBIT ratio for today is -51.20.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Little Green Pharma's Enterprise Value is A$55.75 Mil.
Little Green Pharma's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was A$2.72 Mil. Therefore, Little Green Pharma's EV-to-EBITDA ratio for today is 20.50.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Little Green Pharma's Enterprise Value is A$55.75 Mil.
Little Green Pharma's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was A$42.43 Mil. Therefore, Little Green Pharma's EV-to-Revenue ratio for today is 1.31.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Little Green Pharma (ASX:LGP) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Little Green Pharma's current Enterprise Value is A$55.75 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Little Green Pharma's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was A$-1.09 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Little Green Pharma's current Enterprise Value is A$55.75 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Little Green Pharma's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was A$2.72 Mil.
Little Green Pharma's current Enterprise Value is A$55.75 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Little Green Pharma's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was A$42.43 Mil.
Little Green Pharma's current Enterprise Value is A$55.75 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Little Green Pharma's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was A$0.04 Mil.
Little Green Pharma's current Enterprise Value is A$55.75 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Little Green Pharma's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was A$-0.96 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Little Green Pharma Enterprise Value Related Terms
Little Green Pharma Enterprise Value Historical Data
* Premium members only.
The historical data trend for Little Green Pharma's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Little Green Pharma's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Little Green Pharma Enterprise Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Little Green Pharma's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Little Green Pharma's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Little Green Pharma's Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Little Green Pharma (ASX:LGP) has a Enterprise Value of A$55.75 Mil as of Jun. 28, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Little Green Pharma and its competitors.
Is Little Green Pharma's Enterprise Value too high?
Little Green Pharma's current Enterprise Value is A$55.75 Mil.
How does Little Green Pharma's Enterprise Value compare to ZTS?
Little Green Pharma's Enterprise Value of A$55.75 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Little Green Pharma and its competitors. Little Green Pharma's current Enterprise Value is A$55.75 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Little Green Pharma stock overvalued right now?
Based on GuruFocus' analysis, Little Green Pharma (ASX:LGP) is currently considered Significantly Undervalued. The stock's GF Value™ is A$0.17, compared to a current price of A$0.06 — trading 62.4% below its estimated fair value. The current Enterprise Value is A$55.75 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Little Green Pharma (ASX:LGP), the current Enterprise Value is A$55.75 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). It offers LGP-branded medicinal cannabis oil products in the Australian and European markets. The Group is organized into two operating segments: Australia and Europe (cultivation, production and distribution of cannabis products to Australian and European customers).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:LGP has been successfully added to your 